Updated:
Decibel Therapeutics, Inc.
Decibel Therapeutics, Inc. is identified in the retained SEC EDGAR snapshot dated 2026-10-14. Its SEC Central Index Key is 0001656536, and its reported...
Overview
Decibel Therapeutics, Inc. is identified in the retained SEC EDGAR snapshot dated 2026-10-14. Its SEC Central Index Key is 0001656536, and its reported industry is Pharmaceutical Preparations. In 10-K filed on 2023-03-14, it reported net income of USD -63,005,000; total assets of USD 123,373,000 for the fiscal period ended 2022-12-31. The financial history preserves reporting periods, currencies, filing accessions and source provenance. Figures are reported filing data, rather than real-time estimates.
Company overview
- Legal name
- Decibel Therapeutics, Inc.
- Classification
- Company
- Industry (SIC)
- 2834 — Pharmaceutical Preparations
- Headquarters
- Boston, MA, United States
- Incorporated in
- DE
- Fiscal year end
- December 31
- SEC CIK
- 0001656536
Financials
Annual figures as originally reported. Currency is shown for each fiscal year; B means billion and M means million.
| Fiscal year | Period end | Net income | Total assets | Cash and equivalents | Operating cash flow |
|---|---|---|---|---|---|
| FY2022USD | -$63.0M | $123.4M | $34.6M | -$56.9M | |
| FY2021USD | -$51.8M | $184.5M | $36.5M | -$43.1M |
Recent SEC filings
| Form | Filed | Period | Filing |
|---|---|---|---|
| 8-K | 8-K | ||
| 8-K | 8-K | ||
| SC 13D | — | SC 13D | |
| 10-Q | 10-Q | ||
| 8-K | 8-K | ||
| 8-K | 8-K | ||
| 10-Q | 10-Q | ||
| DEF 14A | DEF 14A | ||
| 8-K | 8-K | ||
| 8-K | 8-K | ||
| 10-K | 10-K | ||
| 8-K | 8-K |
Profile maintained by Altss. Updated: . To correct this record or make a privacy request, send the page URL and your evidence to privacy@altss.com; corrections are free.
Research Decibel Therapeutics, Inc. in Altss
Track this company’s investors, transactions and relationships in Altss.